Table 3 Intraoperative adverse reactions and 30-day postoperative follow-up

Intraoperative adverse reactions, n (%)

  SpO₂ < 90 %

2 (8.0)

1 (3.6)

1 (3.8)

0.685

  P_ETCO₂>45 mmHg

1 (4.0)

5 (17.9)

5 (19.2)

0.213

  SBP < 90mmHg

8 (32.0)

11 (39.3)

19 (73.1)^ab

0.007

  Arrhythmia

2 (8.0)

5 (17.9)

4 (15.4)

0.609

Postoperative pulmonary complications, n (%)

  Total

21 (84.0)

16 (57.1)^a

14 (53.8)^a

0.047

  Hypoxemia

13 (52.0)

4 (14.3)^a

5 (19.2)^a

0.005

  Pulmonary infection

21 (84.0)

14 (50.0)^a

11 (42.3)^a

0.006

  Atelectasis

6 (24.0)

1 (3.6)^a

0 (0.0)^a

0.004

  Acute respiratory distress syndrome

1 (4.0)

1 (3.6)

0 (0.0)

0.764

  Ventilator-associated lung injury

3 (12.0)

3 (10.7)

2 (7.7)

0.902

  Neurogenic pulmonary edema

1 (4.0)

0 (0.0)

1 (3.9)

0.537

Postoperative neurological complications, n (%)

  Intracranial infection

3 (12.0)

3 (10.7)

4 (15.4)

0.915

  Intracranial hypertension

6 (24.0)

7 (25.0)

7 (26.9)

1.000

  Epilepsy

2 (8.0)

2 (7.1)

3 (11.5)

0.890

  Encephaledema

5 (20.0)

5 (17.9)

6 (23.1)

0.939

  Reoperation

2 (8.0)

1 (3.6)

2 (7.7)

0.733

Other

  Mechanical ventilation time, h, median (interquartile range)

72.0 (36.0-105.0)

24.0 (3.0–62.0)^a

24.0 (9.1–66.0)^a

0.006

  Length of stay, days, mean ± SD

21.5 ± 10.4

21.9 ± 8.3

22.0 ± 7.5

0.975

  GOSE score, mean ± SD^c

5 ± 1.6

6 ± 1.3

5 ± 1.2

0.768